Metformin decreases the plasma concentration of pro-atherogenic metabolite trimethylamine N-oxide in an experimental model of type 2 diabetes

Melita Vidējā, Jānis Kūka, Marina Makrecka-Kūka, Jānis Liepins, Solveiga Grīnberga, Eduards Sevostjanovs, Kārlis Vilks, Edgars Liepins, Maija Dambrova

Department of Pharmaceutical Chemistry

Research output: Contribution to conference › Abstract › peer-review

1 Oral presentation

1 results
- Title
- Start date(ascending)

Metformin decreases the plasma concentration of pro-atherogenic metabolite trimethylamine N-oxide in an experimental model of type 2 diabetes
Melita Vidējā (Speaker)
24 Mar 2021
Activity: Talk or presentation types › Oral presentation